Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

TM Dachs; F Duca; R Rettl; C Binder-Rodriguez; D Dalos; LC Ligios; A Kammerlander; E Grunig; Ingrid Pretsch; R Steringer-Mascherbauer; K Ablasser; M Wargenau; J Mascherbauer; IM Lang; C Hengstenberg; R Badr-Eslam; J Kastner; D Bonderman

doi:10.1093/eurheartj/ehac389

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

TM Dachs, F Duca, R Rettl, C Binder-Rodriguez, D Dalos, LC Ligios, A Kammerlander, E Grunig, Ingrid Pretsch (Co-author), R Steringer-Mascherbauer, K Ablasser, M Wargenau, J Mascherbauer, IM Lang, C Hengstenberg, R Badr-Eslam, J Kastner, D Bonderman

Department of Internal Medicine II - Division of Cardiology

Research output: Contribution to journal › Original Article (Journal) › peer-review

37 Citations (Web of Science)

Original language	English
Journal	EUROPEAN HEART JOURNAL
DOIs	https://doi.org/10.1093/eurheartj/ehac389
Publication status	Published - 2022

Keywords

SOLUBLE GUANYLATE-CYCLASE
DYSFUNCTION
VERICIGUAT
STIMULATOR
CAPACITY
PLACEBO
TARGET

Access to Document

10.1093/eurheartj/ehac389

Cite this

Dachs, TM., Duca, F., Rettl, R., Binder-Rodriguez, C., Dalos, D., Ligios, LC., Kammerlander, A., Grunig, E., Pretsch, I., Steringer-Mascherbauer, R., Ablasser, K., Wargenau, M., Mascherbauer, J., Lang, IM., Hengstenberg, C., Badr-Eslam, R., Kastner, J., & Bonderman, D. (2022). Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. EUROPEAN HEART JOURNAL https://doi.org/10.1093/eurheartj/ehac389

Dachs, TM ; Duca, F ; Rettl, R et al. / Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. In: EUROPEAN HEART JOURNAL 2022.

@article{b9fb57f31c0144af8220535fa322f26d,

title = "Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial",

keywords = "SOLUBLE GUANYLATE-CYCLASE, DYSFUNCTION, VERICIGUAT, STIMULATOR, CAPACITY, PLACEBO, TARGET",

author = "TM Dachs and F Duca and R Rettl and C Binder-Rodriguez and D Dalos and LC Ligios and A Kammerlander and E Grunig and Ingrid Pretsch and R Steringer-Mascherbauer and K Ablasser and M Wargenau and J Mascherbauer and IM Lang and C Hengstenberg and R Badr-Eslam and J Kastner and D Bonderman",

note = "[Pretsch, Ingrid] Paracelsus Med Univ Salzburg, Div Cardiol *** Intens Care, Dept Internal Med 2, Muellner Hauptstr 48, A-5020 Salzburg, Austria",

year = "2022",

doi = "10.1093/eurheartj/ehac389",

language = "English",

journal = "EUROPEAN HEART JOURNAL ",

issn = "0195-668X",

publisher = "Oxford Univ Press",

}

Dachs, TM, Duca, F, Rettl, R, Binder-Rodriguez, C, Dalos, D, Ligios, LC, Kammerlander, A, Grunig, E, Pretsch, I, Steringer-Mascherbauer, R, Ablasser, K, Wargenau, M, Mascherbauer, J, Lang, IM, Hengstenberg, C, Badr-Eslam, R, Kastner, J & Bonderman, D 2022, 'Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial', EUROPEAN HEART JOURNAL https://doi.org/10.1093/eurheartj/ehac389

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. / Dachs, TM; Duca, F; Rettl, R et al.
In: EUROPEAN HEART JOURNAL , 2022.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

AU - Dachs, TM

AU - Duca, F

AU - Rettl, R

AU - Binder-Rodriguez, C

AU - Dalos, D

AU - Ligios, LC

AU - Kammerlander, A

AU - Grunig, E

AU - Pretsch, Ingrid

AU - Steringer-Mascherbauer, R

AU - Ablasser, K

AU - Wargenau, M

AU - Mascherbauer, J

AU - Lang, IM

AU - Hengstenberg, C

AU - Badr-Eslam, R

AU - Kastner, J

AU - Bonderman, D

N1 - [Pretsch, Ingrid] Paracelsus Med Univ Salzburg, Div Cardiol *** Intens Care, Dept Internal Med 2, Muellner Hauptstr 48, A-5020 Salzburg, Austria

PY - 2022

Y1 - 2022

KW - SOLUBLE GUANYLATE-CYCLASE

KW - DYSFUNCTION

KW - VERICIGUAT

KW - STIMULATOR

KW - CAPACITY

KW - PLACEBO

KW - TARGET

U2 - 10.1093/eurheartj/ehac389

DO - 10.1093/eurheartj/ehac389

M3 - Original Article (Journal)

C2 - 35909264

SN - 0195-668X

JO - EUROPEAN HEART JOURNAL

JF - EUROPEAN HEART JOURNAL

ER -

Dachs TM, Duca F, Rettl R, Binder-Rodriguez C, Dalos D, Ligios LC et al. Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. EUROPEAN HEART JOURNAL . 2022. doi: 10.1093/eurheartj/ehac389